Status | Study |
Terminated |
Study Name: Development and Assessment of The Polycystic Liver Disease Questionnaire (PLD-Q). Condition: Polycystic Liver Disease Date: 2014-06-20 Interventions: Other: PLD-Q polycystic liver disease questionnaire |
Completed |
Study Name: Ursodeoxycholic Acid as Treatment for Polycystic Liver Disease Condition: Polycystic Liver Disease (PLD): Polycystic Kidney, Autosomal Do Date: 2013-12-12 Interventions: Drug: Ursodeoxycholic Acid The intervention group will receive 15-20mg/kg/day UDCA for 24 weeks |
Active, not recruiting |
Study Name: Pasireotide LAR in Severe Polycystic Liver Disease Condition: Somatostatin Analogs Polycystic Liver Disease Date: 2012-08-17 Interventions: Drug: Pasireotide LAR Injectib |
Completed |
Study Name: The Vienna RAP Pilot Study Condition: ADPKD Date: 2012-05-13 Interventions: Drug: Sirolimus Coated tablets, 1mg and 2mg available. Daily oral single dose with trough levels of 4-8n |
Completed |
Study Name: Somatostatin Analogues as a Volume Reducing Treatment of Polycystic Livers (RESOLVE) Condition: Polycystic Liver Disease Date: 2011-05-13 Interventions: Drug: Lanreotide 120 mg every 28 days intramuscular |
Completed |
Study Name: Lanreotide Autogel in the Treatment of Symptomatic Polycystic Liver Disease Condition: Polycystic Liver Disease Date: 2011-01-11 Interventions: Drug: Lanreotide Autogel 90 mg and 120 mg administration of lanreotide sc every 4 weeks (28 days) |
Completed |
Study Name: Everolimus and LongActing Octreotide Trial in Polycystic Livers Condition: Polycystic Liver Disease Date: 2010-07-06 Interventions: Drug: Everolimus 2.5 mg every |
Terminated |
Study Name: Polycystic Liver Disease in Kidney Transplant Condition: Polycystic Liver Disease Date: 2009-07-06 Interventions: Drug: Tacrolimus Tacrolimus 6- |
Completed |
Study Name: Open-Label Extension of LOCKCYST Trial Condition: Polycystic Liver Disease Hepatomegaly Date: 2008-10-13 Interventions: Drug: lanreotide lanreotide |
Completed |
Study Name: Lanreotide as Treatment of Polycystic Livers Condition: Polycystic Liver Disease Hepatomegaly Date: 2007-11-28 Interventions: Drug: Placebo Drug: Lanreotide |